Brown University researchers have developed a new artificial intelligence method for predicting the rate at which materials ...

Controlled drug delivery systems based on in situ forming implants offer a versatile platform for achieving sustained and localised therapeutic release from a single administration. These systems ...

Controlled drug delivery systems encompass a range of engineered carriers—such as microspheres, nanoparticles, liposomes, hydrogels and implantable devices—designed to release therapeutic agents at ...

Patient-centric drug development is a concept that has proven to be divisive: Some see it as nothing but a buzzword, while others have embraced the concept completely. Either way, it has garnered much ...

Ultrasound can open and rebuild molecular nanocages, enabling controlled release of cancer drugs and advancing targeted drug ...

A recent study published in Nature Communications showcased a breakthrough in transdermal drug delivery. Scientists have developed an electrically activated patch with biocompatible metallic membranes ...

Biodegradable polymers are a type of polymer that exists both naturally and can be synthesized in laboratories. This special class of polymer is broken down naturally by microbial processes to produce ...

Upon administration, VLPs are uptake by APC, like dendritic cells. VLPs can be presented by MHC-I or MHC-II, which are recognized by CD8+ and CD4+ T cells, respectively. For cellular response, CD8+ ...

The spongelike structure of metal organic frameworks (MOFs) allows these polymers to possibly carry and deliver a range of therapeutic compounds. Now, researchers treated a chromium-containing MOF ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

The global long-acting drugs market is growing steadily, expected to be valued at around US$ 7.2 billion in 2026 and projected to reach US$ 13.3 billion ...